JPRN-UMIN000039167招募中未知
Biomarker study of immunological response in Japanese patients with stage III non-small cell lung cancer receiving chemoradiotherapy followed by durvalumab - Dual-Bio study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) previously treated with PD-1/PD-L1 inhibitors or anti CTLA-4 antibody
研究者
相似试验
已完成
3 期
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese InfantsInfections, RotavirusRotavirus VaccinesNCT00480324GlaxoSmithKline765
已完成
4 期
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DoseEncephalitis, JapaneseNCT02514746PATH561
已完成
不适用
An ancillary biomarker study of Gio-Tag Japan.on-small cell lung cancerJPRN-UMIN000043299HANSHIN Oncology Group93
Unknown
4 期
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ChildrenJapanese EncephalitisNCT01954810Khon Kaen University88
尚未招募
3 期
ong Term Immunogenicity of the JE Vaccine IC51Prophylactic Vaccine against Japanese EncephalitisNeurological - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12605000681651Intercell AG600